Overall rank by patents
#31,162
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
The verdict
Christiana holds 8 US patents across 10 technology areas, rank #31,162 of 50,000 tracked assignees.
Christiana CARE Health System, Inc. has been granted 8 US utility patents between 2021 and 2025, placing Christiana CARE Health System, Inc. at rank #31,162 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.0 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Christiana CARE Health System, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Christiana sits between Chinese Academy OF Inspection AND Quarantine (8 patents, rank #31,158) and Chunghwa Chemical Synthesis & Biotech Co. Ltd. (8 patents, rank #31,166) - the closest US assignees by grant volume. The composite Innovation Score of 53.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Christiana CARE Health System, Inc.'s 24.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Christiana CARE Health System, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHINESE ACADEMY OF INSPECTION AND QUARANTINE
8 patents
CHIOME BIOSCIENCE INC.
8 patents
CHO PHARMA, INC.
8 patents
CHR.MAYR GMBH + CO. KG
8 patents
CHULALONGKORN UNIVERSITY
8 patents
CHUN KUANG OPTICS CORP.
8 patents
CHUNG-HSIN ELECTRIC &MACHINERY MFG. CORP.
8 patents
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. LTD.
8 patents
CHRISTIANA CARE HEALTH SYSTEM, INC.
8 patents
What this shows Christiana holds 8 patents at rank #31,162, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,162 in granted patent volume.
Other assignees with the most granted patents in Christiana's primary technology class.
Christiana's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
53 Top 9% higher than 91% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 12.5% |
| 2023 | 2 | 25.0% |
| 2024 | 2 | 25.0% |
| 2025 | 3 | 37.5% |
Top 10 of 10 technology areas
Overall rank by patents
#31,162
Across all tracked assignees
53.2 out of 100
How to use this portfolio
Christiana's 8 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.